Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Genzyme Updates Cerezyme Supply; Responds to Sanofi Bid
- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
Clinical Trials News- Clinilabs Selected for a Phase I/II Study of HIV Vaccine
- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
Blogroll
-
Meta
Category Archives: Meetings
Pharma Buzz Noticeably Absent at JPMorgan's 2008 Healthare Conference
We didn’t get to travel to this year’s JPMorgan Healthcare Conference, but Pharm Exec contributor Audrey S. Erbes (founder of Erbes & Associates) did. Here are her impressions:
There was a lack of usual excitement among drug companies but no sense of distress.
Although this year’s event broke attendance records with more than 7,700 participants and 331 [...]
Also posted in Deals Leave a comment

FMCP and Performance-Based Pricing